Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, TPX, Peacefulwendy, $Pistol Pete$, thenewmixer, fraum
Search This Board: 
Last Post: 8/23/2017 3:44:41 AM - Followers: 790 - Board type: Free - Posts Today: 7

Welcome to PharmaCyte BioTech
An OTCQB Company

PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.



FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment

European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

 Company Address
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

817,204,665 a/o Aug 29, 2016

For more updated information please visit:

Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations

Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States


   All News Releases:


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans. 

Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director

Carlos A. Trujillo – Chief Financial Officer and Director

Walter H. Gunzburg – Chief Scientific Officer

Dr. Matthias Lohr as Chairman of Scientific Advisory Board

Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board





-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Annual Report (10-k) 07/27/2017 05:24:39 PM
PMCB News: PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer 07/26/2017 09:00:00 AM
PMCB News: PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors 07/10/2017 09:30:00 AM
PMCB News: Current Report Filing (8-k) 07/10/2017 06:04:49 AM
PMCB News: PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event 07/06/2017 09:00:00 AM
#69766  Sticky Note $PMCB Institutional Investors PMCB $Pistol Pete$ 06/10/17 11:37:09 PM
#68353  Sticky Note PMCB NEWS! PharmaCyte Biotech Updates IND Submission Process TPX 05/08/17 09:12:03 AM
#62231  Sticky Note in full/ #2/ 01-28-2017/ Keeping an Eye on mick 01/28/17 07:35:33 PM
#52881  Sticky Note Here is a very nice list of accomplishments... Peacefulwendy 09/28/16 11:17:44 AM
#74130   A game changing technology for cell therapies 1234jklm 08/23/17 03:44:41 AM
#74129   Kw currently involved with diabetes trials for ciab 1234jklm 08/23/17 03:15:27 AM
#74128   Has KW been part of any trials? JimboPMCB 08/23/17 01:03:48 AM
#74127   If you want a company that rushes...ahead..making..mistakes 1234jklm 08/23/17 12:46:16 AM
#74126   Even big pharma expect development to take 5-15 years 1234jklm 08/23/17 12:22:40 AM
#74125   '1234jklm', best post I've seen here for a pennyvestor 08/23/17 12:12:28 AM
#74124   In your last sentence I would have added JimboPMCB 08/23/17 12:08:54 AM
#74123   Gates von hoff Simpson or the dissapointed? 1234jklm 08/22/17 11:29:39 PM
#74122   A constant misunderstanding about the company 1234jklm 08/22/17 10:40:58 PM
#74121   Partnership and IND coming 4Q17: rudygerner 08/22/17 09:46:03 PM
#74120   31 shares of PMCB or a $2 powerball concordia 08/22/17 08:19:20 PM
#74119   Join the PMCB Facebook group and click on JimboPMCB 08/22/17 07:49:55 PM
#74118   I just laugh...when kaboom starts...many people will chase efood125 08/22/17 07:47:25 PM
#74116   Its called dumping shares PMCB sold to them concordia 08/22/17 07:39:37 PM
#74115   My dd sez...waggs got fda and ema ODD... efood125 08/22/17 07:38:11 PM
#74114   How many years have you posted this same concordia 08/22/17 07:36:16 PM
#74113   Funny how the date published is missing. But concordia 08/22/17 07:34:03 PM
#74112   Lol. Huge anticipation. There's been a lot of Fordman65 08/22/17 07:28:07 PM
#74111   What's your DD say about KW??? JimboPMCB 08/22/17 07:25:19 PM
#74110   Thanks for posting one of many lies by thenewmixer 08/22/17 07:21:50 PM
#74109   how many time is PMCBs fake Consortium going thenewmixer 08/22/17 07:11:45 PM
#74108   People buy....people sell....I never follow the crowd...I do efood125 08/22/17 06:44:29 PM
#74107 Brian903 08/22/17 06:13:52 PM
#74106   nice red close:) PMCB closes red 9 out thenewmixer 08/22/17 05:17:26 PM
#74105   For a company with such anticipation coming and hockeypond 08/22/17 04:49:53 PM
#74104   Next episode of American Greed will feature KW JimboPMCB 08/22/17 04:09:44 PM
#74103   All a Hoax. The technology has a good JimboPMCB 08/22/17 02:03:03 PM
#74102   "timely fashion" - may mean 2 - 3 NEWgene55 08/22/17 01:29:36 PM
#74101   I hope I get the chance to "eat NEWgene55 08/22/17 01:26:07 PM
#74100   Is it possible those shares sold at a oldmusky 08/22/17 01:24:22 PM
#74099   Thanks for putting those up - Just shows NEWgene55 08/22/17 01:22:05 PM
#74098   "Fast Track" - what a laugh - almost NEWgene55 08/22/17 01:17:05 PM
#74095   ETF tomorrow ???? rcstock 08/22/17 12:18:13 PM
#74093   Meanwhile, CAR-T cells are on the verge of takeyouhigher 08/22/17 10:59:11 AM
#74091   LOL. The only thing KW has tighter then concordia 08/22/17 10:51:18 AM
#74090   Nuvilex Eyes FDA Fast Track After ABRAXANE Approved concordia 08/22/17 10:48:03 AM
#74089   kw has it tighter than a drum. tulla236a 08/22/17 10:41:49 AM
#74088   Good morning Everyone $Pistol Pete$ 08/22/17 10:23:12 AM
#74087   not very exciting here......not a word from PMCB thenewmixer 08/22/17 10:16:41 AM
#74086   We all feel that the suggested changes we concordia 08/22/17 10:12:38 AM
#74085   Good morning Pete, and all, very exciting here. oldmusky 08/22/17 10:06:47 AM
#74084   Partnership and IND coming 4Q17: rudygerner 08/22/17 09:30:32 AM
#74082   how many of this false prs has KW thenewmixer 08/22/17 06:58:48 AM
#74081   wow how many times is KW going to thenewmixer 08/22/17 06:56:25 AM
#74080   Sorry highest purchase price around 0.26p The Promised Land 08/22/17 04:27:50 AM
#74078   Thank you, always good to see common sense frosr6 08/22/17 12:22:15 AM
#74077 opinion....based on his it a coincidence efood125 08/21/17 09:39:41 PM
#74076   " findings to J&J...and poof...he is gone...." PINKribbon 08/21/17 09:01:09 PM
#74075   $PMCB PharmaCyte Biotech Appoints Former Johnson & Johns $Pistol Pete$ 08/21/17 08:12:44 PM
#74074   Sanjay Batra....look up his background...pmcb and J&J could efood125 08/21/17 08:06:58 PM